SCHEMBL23446732

SCHEMBL23446732

CC1(C)CCC(C)(C)c2cc(N(c3cc(Cl)cc(C#N)c3)c3cccc4c3C(C)(C)CCC4(C)C)c(-c3ccccc3)cc21

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 1/20 0.31
▸ PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23446797 0.86 RXRA (0.32) —
SCHEMBL23446802 0.76 — —
SCHEMBL23445503 0.76 — —
SCHEMBL23442476 0.74 RXRA (0.34) PGR
SCHEMBL23445012 0.73 TP53 (0.31) —
SCHEMBL23442801 0.72 RXRA (0.37) —
SCHEMBL24085002 0.70 — —
SCHEMBL26944584 0.69 RARB (0.34) —
SCHEMBL26949642 0.69 RARB (0.34) —
SCHEMBL26946355 0.69 RXRA (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
WO-2021107681-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780856-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, LEF1 ACLY 3699/4885PGR 2093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback